INOVIO Reports Positive Interim Phase 1/2 Trial Results For INO-3107 For Respiratory Papillomatosis

RTTNews | 1029天前
INOVIO Reports Positive Interim Phase 1/2 Trial Results For INO-3107 For  Respiratory Papillomatosis

(RTTNews) - Biotechnology company Inovio Pharmaceuticals Inc. (INO) announced Thursday positive interim results from an ongoing Phase 1/2 clinical trial evaluating INO-3107 for the treatment of HPV 6 and HPV 11-associated Recurrent Respiratory Papillomatosis (RRP) in adults.

In the first cohort of 21 participants, INO-3107 showed a statistically significant improvement in the clinical endpoint of the number of surgical interventions needed to control papilloma growth.

INO-3107 was also observed to be well-tolerated and immunogenic in the trial. INO-3107 received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) in July 2020.

INO-3107 was evaluated in a Phase 1/2 open-label, multicenter trial to assess its safety, tolerability, immunogenicity, and efficacy in 32 participants with HPV 6 and/or HPV 11-associated RRP.

Results from the second cohort of 11 patients are expected in the first half of 2023.

For More Such Health News, visit rttnews.com

read more
Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP

Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP

Biotechnology company Inovio Pharmaceuticals, Inc. (INO) announced Tuesday that it has received feedback from the U.S. Food and Drug Administration (FDA) that data from its completed Phase 1/2 trial of INO-3107 for the treatment of RRP could support INOVIO's submission of a BLA for review under the FDA's accelerated approval program.
RTTNews | 667天前
Australian Market Trims Early Losses In Mid-market

Australian Market Trims Early Losses In Mid-market

The Australian stock market is trimming its early losses in mid-market moves on Friday, extending the slight losses in the previous session, following the mixed cues from Wall Street overnight. The benchmark S&P/ASX 200 is staying below the 8,850 level, with weakness in financial and technology stocks partially offset by gains in mining stocks.
RTTNews | 38分钟前
Asian Markets Mixed Amid Tariff Caution

Asian Markets Mixed Amid Tariff Caution

Asian stock markets are trading mixed on Friday, following the mixed cues from Wall Street overnight, as uncertainty continues over US reciprocal tariffs despite the tariff's kicking in on Thursday. Market uncertainty is created by the pressure tactics exerted by the US by constantly altering tariffs. Asian markets ended mostly higher on Thursday.
RTTNews | 41分钟前
Sensex, Nifty Set To Open Lower On Trade Concerns

Sensex, Nifty Set To Open Lower On Trade Concerns

Indian shares look set to open on a sluggish note Friday as U.S. President has ruled out any possibility of trade negotiations with India and Prime Minister Narendra Modi said India would not compromise on the interests of its farmers, fishermen or livestock rearers, even if it meant paying "a heavy personal price."
RTTNews | 1小时23分钟前
Thai Stock Market May Spin Its Wheels On Friday

Thai Stock Market May Spin Its Wheels On Friday

The Thai stock market has moved higher in four straight sessions, gathering almost 50 points or 4.1 percent along the way. The Stock Exchange of Thailand now sits just above the 1,265-point plateau although it may be stuck in neutral on Friday.
RTTNews | 1小时57分钟前